| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |